Among AML patients, the risk of relapse was comparable between those not in CR and those who were in CR at the time of HCT, suggesting that the regimen was fairly effective in controlling some of the high-risk diseases. This was corroborated by the finding of similar risk of relapse among...
而来自英国的数据表明,与之前的德尔塔变体相比,奥密克戎引起长病程症状的可能性大幅降低。 Both studies have found that women, older people, those who had suffered from diseases before infection, and those living in poorer area...
From the high mortality rates in older population and patients with underling diseases but low mortality rates in young adults, we can suppose that the outcomes of COVID-19 are significantly affected by the immune responses of patients. Especially for the long-term SARS-CoV-2 infection, the low...
standardizing the proposed approach for other diseases and adapting it to intervene at an earlier stage could achieve substantial cost savings. In addition, the proposed method can be scaled to prevent and manage other diseases such as type 2 diabetes, obesity, and arthritis, thereby improving the...
Sirolimus is increasingly utilized in treating diseases associated with mTOR pathway overactivation. Despite its potential, the lack of evidence regarding its long-term safety across all age groups, particularly in pediatric patients, has limited its further application. This study aims to assess the lo...
Because obesity contributes to many diseases, medications to help patients lose weight and sustain weight loss could potentially lead to improvements in multiple domains. Weight loss achieved through lifestyle modification and bariatric surgery has been shown to result in many such improvements; however,...
However, the long-term effects on cardiovascular diseases are poorly understood. An OPs-exposed cohort (N = 7,561) and an age- and gender-matched control cohort (N = 30,244), both identified from the National Health Insurance Research Database, were compared. We utilized the multivariable ...
Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain Pablo Martinez-Martin Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia Glenda M. Halliday Hea...
the gut microbiome has long been considered a potential direction for the treatment of gastrointestinal diseases. A previous study proved that 5-hydroxytryptamine signaling mediated by gut microbiome dysregulation probably contributed to the gastrointestinal manifestations of long COVID.251Thus, certain agents...